Next, we first established ERK1/2 function in endothelial dysfunction using the U0126 MEK inhibitor, which effectively blocked thrombin-stimulated ERK1/2 phosphorylation in human cultured endothelial cells (Fig. 5B, Inset). This evidence concerns the gene MAPK3 and endothelial dysfunction.